BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/11/2021 11:07:19 AM | Browse: 475 | Download: 976
 |
Received |
|
2021-01-24 14:06 |
 |
Peer-Review Started |
|
2021-01-24 14:16 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-02-22 14:03 |
 |
Revised |
|
2021-03-02 20:37 |
 |
Second Decision |
|
2021-04-20 13:21 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-04-22 04:53 |
 |
Articles in Press |
|
2021-04-22 04:53 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2021-04-29 13:01 |
 |
Publish the Manuscript Online |
|
2021-05-11 11:07 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Surgery |
Manuscript Type |
Minireviews |
Article Title |
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
|
Manuscript Source |
Invited Manuscript |
All Author List |
Alessandro Fancellu, Valeria Sanna, Fabrizio Scognamillo, Claudio F Feo, Gianpaolo Vidili, Giuseppe Nigri and Alberto Porcu |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Alessandro Fancellu, FACS, MD, PhD, Associate Professor, Research Scientist, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2 - Clinica Chirurgica, University of Sassari, V.le San Pietro 43, Sassari 07100, Italy. afancel@uniss.it |
Key Words |
Hepatocellular carcinoma; COVID-19; Hepatic resection; Liver transplant; Ablation |
Core Tip |
Guidelines on the surgical management of hepatocellular carcinoma have been recently adapted to the prioritization of health resources to the care of patients with COVID-19. There has been a reduction in hepatic resection and liver transplant activity, which need to be restricted to very selected cases. For patients in whom surgery cannot be performed in due time, alternative or delaying strategies, mostly ablation or transarterial therapies, should be considered. The decision on surgical management should be based on risk stratification and the balance between the increased risk of COVID-19 infection, the urgency of the intervention, and the oncological effects of delayed treatment and shared with patients. |
Publish Date |
2021-05-11 11:07 |
Citation |
Fancellu A, Sanna V, Scognamillo F, Feo CF, Vidili G, Nigri G, Porcu A. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World J Clin Cases 2021; 9(15): 3517-3530 |
URL |
https://www.wjgnet.com/2307-8960/full/v9/i15/3517.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v9.i15.3517 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345